Monitor shareholder vote results for any split between management-supported and ISS-recommended outcomes, particularly on director elections. While the compensation issue is historical and governance-related, sustained ISS opposition could signal future governance scrutiny, especially if director pay trends diverge from peers.
Price Chart
Executive Summary
Cohen & Steers is urging shareholders to vote for all director nominees, including independent directors, ahead of its April 30, 2026 annual meeting. The company is defending against an ISS recommendation against certain nominees due to concerns over elevated reported compensation for co-founder Martin Cohen, driven by a $300,000 reimbursement for HSR Act filing fees and longstanding medical benefits.
Key Financial Metrics
Key Facts
- The filing is a definitive additional proxy solicitation sent by management ahead of the April 30, 2026 annual meeting.
- The company is seeking shareholder support to elect nine director nominees, including co-founders Martin Cohen and Robert H. Steers.
- ISS recommended voting against several independent director nominees due to perceived excessive compensation linked to Cohen’s $300,000 HSR fee reimbursement and lifetime medical benefits.
- The employer-paid cost of medical benefits for Cohen and family in 2025 was $24,984, consistent with prior years.
- Without the $300,000 reimbursement, Cohen’s 2025 total compensation would have been $414,946; with it, reported compensation was $714,946.
Financial Impact
The $300,000 HSR fee reimbursement increased reported director compensation for Martin Cohen by 72%, but no new costs were incurred related to medical benefits. The clarification of lifetime spousal coverage introduced no incremental cost.
Risk Factors
- Potential for shareholder dissent if institutional investors follow ISS and withhold votes from independent directors.
- Reputational risk from perception of excessive founder-related benefits, despite board justification.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001284812-26-000039 |
| Document: 0001284812-26-000039-index-headers.html | 0001284812-26-000039 |
| Document: 0001284812-26-000039-index.html | 0001284812-26-000039 |
| Document: 0001284812-26-000039.txt | 0001284812-26-000039 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 8-K | $69.63 $71.00 | ▲ +1.97% | ▲ +2.40% | $70.95 (+1.90%) |
Oct 15, 2026 11d ago | Press Release | $69.63 $71.00 | ▲ +1.97% | ▲ +2.40% | $70.95 (+1.90%) |
Aug 17, 2026 10w ago | Press Release | $83.34 $83.16 | ▼ −0.22% | ▲ +0.97% | $70.95 (−14.87%) |
Jul 16, 2026 14w ago | Press Release | $84.65 $79.98 | ▼ −5.52% | ▼ −4.83% | $70.95 (−16.18%) |
Jul 8, 2026 15w ago | Press Release | $76.90 $81.07 | ▲ +5.42% | ▲ +5.55% | $70.95 (−7.74%) |
Jun 11, 2026 19w ago | Institutional Cluster | $76.02 $74.35 | ▼ −2.20% | ▼ −2.63% | $70.95 (−6.67%) |
May 21, 2026 22w ago | 8-K | $71.84 $70.54 | ▼ −1.81% | ▼ −3.47% | $70.95 (−1.24%) |
Apr 20, 2026 27w ago | DEFA14A | $67.62 $68.15 | ▲ +0.78% | ▼ −0.13% | $70.95 (+4.92%) |
Apr 16, 2026 27w ago | 8-K | $66.06 $67.71 | ▲ +2.50% | ▲ +1.95% | $70.95 (+7.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers